Next Article in Journal
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study
Next Article in Special Issue
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Previous Article in Journal
Incidence of Severe COVID-19 Outcomes and Immunization Rates in Apulian Individuals with Inflammatory Bowel Disease: A Retrospective Cohort Study
Previous Article in Special Issue
SARS-CoV-2-Vaccine-Related Endocrine Disorders: An Updated Narrative Review
 
 
Article

Article Versions Notes

Vaccines 2024, 12(8), 882; https://doi.org/10.3390/vaccines12080882
Action Date Notes Link
article pdf uploaded. 2 August 2024 17:54 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/882/pdf-vor
article supplementary file uploaded. 2 August 2024 17:54 CEST - https://www.mdpi.com/2076-393X/12/8/882#supplementary
article xml file uploaded 5 August 2024 05:14 CEST Original file -
article xml uploaded. 5 August 2024 05:14 CEST Update -
article pdf uploaded. 5 August 2024 05:14 CEST Updated version of record https://www.mdpi.com/2076-393X/12/8/882/pdf-vor
article html file updated 5 August 2024 05:16 CEST Original file -
article xml file uploaded 5 August 2024 08:31 CEST Update -
article xml uploaded. 5 August 2024 08:31 CEST Update https://www.mdpi.com/2076-393X/12/8/882/xml
article pdf uploaded. 5 August 2024 08:31 CEST Updated version of record https://www.mdpi.com/2076-393X/12/8/882/pdf
article html file updated 5 August 2024 08:33 CEST Update https://www.mdpi.com/2076-393X/12/8/882/html
Back to TopTop